Leprosy occurring as immune reconstitution syndrome

Area of Science:

• Infectious Diseases
• Immunology
• Public Health

Background:

• Immune reconstitution inflammatory syndrome (IRIS) is a clinical condition observed in HIV-infected individuals initiating highly active antiretroviral therapy (HAART).
• Leprosy has been identified as a specific manifestation of IRIS, necessitating clinical awareness, particularly in endemic areas.
• Published literature since 2003 documents 19 cases of IRIS, highlighting its occurrence and impact.

Purpose of the Study:

• To define the criteria for diagnosing leprosy as an IRIS.
• To emphasize the importance of recognizing leprosy-associated IRIS in clinical practice.
• To provide a framework for identifying and managing this specific condition.

Main Methods:

• The study outlines a case definition for leprosy as IRIS based on clinical presentation, immune restoration, and timing of onset.
• Key criteria include leprosy or type 1 reaction within six months of HAART initiation.
• Additional criteria involve advanced HIV infection, a low pre-HAART CD4+ count, and a subsequent increase in CD4+ count post-HAART.

Main Results:

• A clear case definition for leprosy as IRIS has been established.
• The definition integrates clinical leprosy presentation with immunological markers of HAART response.
• The criteria aim to facilitate accurate diagnosis and timely management.

Conclusions:

• Leprosy-associated IRIS requires recognition, especially in regions where both HIV and leprosy are prevalent.
• The incidence of leprosy-associated IRIS is expected to rise with increased access to HAART.
• Further research into the pathogenic mechanisms of leprosy-associated IRIS is warranted.